The phase one trial will test how safe and effective the new shot is against the variant — known as B.1.351 — in roughly 210 healthy adults. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.